By: Chang Min-hsuan, Chen Yi-hsuan and Ko Lin
Speaking at a daily CECC briefing in Taipei, Chang said remdesivir is a highly anticipated drug that many believe could be a potential treatment for COVID-19 patients.
Originally developed by the American drugmaker Gilead Sciences for use against the Ebola virus, remdesivir has been widely discussed as a possible coronavirus treatment, following positive results from Chinese and American doctors who have administered the drug experimentally.
On Jan. 31, Gilead said in a statement that it was working with the Chinese authorities to conduct a clinical trial involving the use of remdesivir on coronavirus patients. [FULL STORY]